Standard Biotools (LAB) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 413.00 |
| Dec 31, 2025 | -582.00 |
| Sep 30, 2025 | 1,594.00 |
| Jun 30, 2025 | 2,149.00 |
| Mar 31, 2025 | 2,143.00 |
| Dec 31, 2024 | 1,615.00 |
| Sep 30, 2024 | 862.00 |
| Jun 30, 2024 | 899.00 |
| Mar 31, 2024 | 509.00 |
| Dec 31, 2023 | 1,301.00 |
| Sep 30, 2023 | -469.00 |
| Jun 30, 2023 | -472.00 |
| Mar 31, 2023 | -939.00 |
| Dec 31, 2022 | -957.00 |
| Sep 30, 2022 | -348.00 |
| Jun 30, 2022 | -487.00 |
| Mar 31, 2022 | -1,017.00 |
| Sep 30, 2021 | -785.00 |
| Jun 30, 2021 | -560.00 |
| Mar 31, 2021 | -461.00 |
| Dec 31, 2020 | -436.00 |
| Sep 30, 2020 | -367.00 |
| Jun 30, 2020 | -665.00 |
| Mar 31, 2020 | -862.00 |
| Dec 31, 2019 | -847.00 |
| Sep 30, 2019 | -1,005.00 |
| Jun 30, 2019 | -1,082.00 |
| Mar 31, 2019 | -658.00 |
| Dec 31, 2018 | -93.00 |
| Sep 30, 2018 | -327.00 |
| Jun 30, 2018 | -555.00 |
| Mar 31, 2018 | -530.00 |
| Dec 31, 2017 | -537.00 |
| Sep 30, 2017 | -402.00 |
| Jun 30, 2017 | 544.00 |
| Mar 31, 2017 | 808.00 |
| Dec 31, 2016 | 476.00 |
| Sep 30, 2016 | 449.00 |